Introduction
Materials and methods Transgenic mouse models that contain alterations of specific Animals genes known to be involved in human cancers are being C57BL/6, C57BL/6 p53 ϩ/-mice, FVB/N and FVB/N Tg.AC, were obtained from Taconic Farms (Germantown, NY) at~4-5 weeks of age, held for [1] [2] [3] proposed as useful short-term carcinogenicity bioassays and weeks and acclimated to wire caging within the inhalation chamber 1 week as alternatives to the conventional chronic rodent bioassays prior to initiation of benzene exposure. At the initiation of benzene exposure (Tennant et al., 1995 (Tennant et al., , 1996 Gulezian et al., 2000) . Two mice ages ranged from 6 to 9 weeks. Water (reverse osmosis-treated) and transgenic mouse tumor models, one carrying an activated commercially available rodent diet were available ad libidum, and feed exposed to benzene was discarded following each exposure period. Mice were form of the ras oncogene v-Ha-ras (Tg.AC mice) and another kept in a reverse day-night cycle (lights on at 1 am, off at 1 pm); exposure Ͻ8%. The average temperatures ranged from 71.1 to 72.8°F and the average took place during the light cycle. Each exposure or control group was housed relative humidity from 49 to 57% for the four exposure groups. in a separate 8 m 3 inhalation chamber, and all mice were individually housed Micronucleus assay in stainless steel wire mesh cages. The institutional Animal Use and Care
The micronucleus assay was based on the procedures of Dertinger et al. Committee of the Chemical Industry Institute of Toxicology (CIIT) approved (1996) . Micronucleus frequencies were determined on three to four mice per all conditions and animal use. time point and 10 000 cells were analyzed from each mouse. Sample Experimental design preparation and micronucleus evaluation were performed as described in a This study used three benzene exposure groups: two at 100 p.p.m., one at beta-version test kit of MicroFlowPlus™ Mouse Micronucleus Assay Kit 200 p.p.m. and one control unexposed group at 0 p.p.m. Start dates for each (Stratagene, La Jolla, CA) . Approximately 50 µl of blood, collected from the exposure group were staggered at intervals of 1-2 weeks apart and no retro-orbital plexus during isofluorane (IsoFlo ® , Abbott Laboratories, Chicago, exposures were conducted at the weekend. The control group and one group IL) anesthesia, was suspended in 300 µl Hank's balanced salt solution (Sigma at 100 p.p.m. benzene were placed in whole-body 8 m 3 inhalation chambers Chemical H6648, St Louis, MI), with 500 U/ml heparin (Sigma Chemical for 5 days/week 6 h/day (Monday to Friday, M-F), while the other group at H3393). The suspension was injected directly into 2 ml cold methanol 100 p.p.m. benzene was exposed based on an every-other-day schedule:
(approximately -80°C), struck sharply to dissociate aggregated cells and 3 days/week (Monday, Wednesday, Friday, MWF) 10 h/day. The group at 200 stored at -80°C until analysis. To prepare cells for analysis, tubes were struck p.p.m. was exposed based on the every-other-day schedule: 3 days/week 5 h/ sharply several times when removed from the freezer, and 10 ml of bicarbonateday (MWF). This schedule maintained all benzene-exposed groups at an buffered saline (0.9% NaCl ϩ 5.3 mM sodium bicarbonate) were added. The equal total exposure level of 3000 p.p.m.ϫh/week (Figure 1 ). To determine cells were isolated by centrifugation and stained according to the manufacmicronuclei in peripheral blood, animals (n ϭ 3-4) were bled at exposure turer's recommendations. Cells were incubated in a working solution of weeks 1, 5, 9 and 13, then after~6 months exposure.
fluorescein isothiocyanate (FITC) conjugated antibody and RNase and resusBlood collected for the final determination of micronuclei in mice was done pended in propidium iodide (PI) for analysis. over a single week for logistical considerations. Due to the staggered start dates for the exposed groups, this corresponded to weeks 33-37.
Flow cytometric analysis of micronucleated red blood cells (MN-RBC) and micronucleated reticulocytes (MN-RET) Inhalation exposures
Animals were exposed for up to 38 weeks in 8 m 3 inhalation chambers to
The flow cytometric analyses were carried out on a FACS Vantage flow target benzene concentrations of 100 p.p.m. or 200 p.p.m. Benzene concentracytometer (Becton Dickenson, San Jose, CA). The laser was tuned to provide tions were generated by metering known amounts of liquid benzene into a 488 nm excitation with UV set at 20 mW as the regulation beam. The FL1 heated j-tube. The benzene vaporized in the j-tube and was carried in a photomultiplier tube was used with a filter (DF 530/30) for the green (FITC) nitrogen stream to the HEPA-filtered 8 m 3 chamber air supply where it was signal, and FL2 was used for the red (PI) signal using a 580 LP filter. Malariadiluted to the target concentrations. The 8 m 3 chamber air supply flowed at infected mouse blood was used as a reference standard for consistentlỹ 1800 l/min and was conditioned to~72°F and 50% relative humidity. The defining micronucleus analysis windows, as well as establishing proper PMT unexposed control chambers (0 p.p.m.) operated under similar environmental voltages and compensation on a daily basis (Dertinger et al., 1999) . Micronuclei conditions. The environmental conditions were monitored continuously; 30 min were identified in PI positive cells, and reticulocytes (RET) were identified averages were recorded and printed daily.
as CD71 (transferrin receptor)-FITC positive cells. A solution of 1% Clorox™ Analysis of benzene exposures bleach with 50 mM NaOH in distilled water was passed through the sample line for~1 min between each sample. Benzene exposure concentrations were measured with four calibrated infrared spectrophotometers (MIRAN 1A, The Foxboro Co., Foxboro, MA) with one Statistics spectrophotometer sampling each chamber. Voltages from the spectrophotoMultivariate analysis of the MN-RBC, MN-RET and RET frequencies was meter corresponding to the benzene exposure concentration were transmitted used to determine whether there were global interactions between time points, to the Andover Infinity Building Automation System (Andover Controls Corp., groups and genotypes. As a global interaction was present between these Andover, MA), logged and printed in a daily report. The distribution of parameters, data sets were individually evaluated with a univariate two-way benzene was checked at nine locations in each of the exposure chambers prior analysis of variance (ANOVA) using contrasts of least square means to to the initiation of exposure. determine treatment effect within each time point. Statistical significance was The average exposure concentrations (Ϯstandard deviation, SD) of benzene determined at a P ϭ 0.05 Bonferonni-corrected for the appropriate number for the 100 p. collected following that day's exposure. MN-RET occurred at Results a higher frequency in the FVB/N background mice (wild-type Total micronuclei and Tg.AC mice) as compared with the C57BL/6 background After 1 week benzene exposure, total MN-RBC frequencies mice (wild-type and p53ϩ/-mice) ( Figure 3A and B). had increased in all exposure groups and in all genotypes Reticulocytes compared with the unexposed 0 p.p.m. controls. There was a
In the FVB/N background mice (wild-type and Tg.AC mice), cumulative increase in MN-RBC frequency with time up to total RET (CD-71 positive cells) were decreased in the 100 13 weeks exposure. At~6 months exposure, there was no p.p.m. M-F group compared with unexposed controls. In the increased MN-RBC frequency above the level determined at C57BL/6 background mice (wild-type and p53ϩ/-mice) there 13 weeks (number of weeks at the 6 month time point differ was no difference in total RET in benzene-exposed mice because of staggered start dates). All genotypes had fewer compared with unexposed controls. Total RET were increased MN-RBC when exposed to 200 p.p.m. MWF as compared above controls in all genotypes exposed to benzene 100 p.p.m. with 100 p.p.m. MWF or M-F (Figure 2A and B) . There was MWF ( Figure 4A and B). Tg.AC mice had a higher frequency no difference in the frequency of MN-RBC between the wildof RET in the 200 MWF group compared with the FVB/N type FVB/N and Tg.AC mice. Among the benzene-exposed animals in the same exposure group ( Figure 4B ). groups, p53ϩ/-mice had significantly fewer MN-RBC than the isogenic C57BL/6 controls at one or more time points ( Figure 2B) .
Discussion

Micronucleated reticulocytes
This study is based on the analysis of peripheral blood to detect micronucleus formation following inhalation exposure MN-RET were significantly increased with time by benzene exposure above the unexposed 0 p.p.m. controls in all genoto benzene in p53ϩ/-mice, Tg.AC mice and their isogenic parental strains (C57BL/6 and FVB/n, respectively). In additypes. Technical errors at the week 5 time points in the 100 p.p.m. MWF exposure groups prevented accurate detertion, to investigate the impact of daily versus every-other-day exposures, three different exposure protocols that exposed the mination of MN-RET. At week 1 in the 200 p.p.m. MWF group, the low MN-RET results may reflect recent cytotoxic mice to the same weekly exposure of 3000 p.p.m.ϫh/week were used. The mice in the 100 p.p.m. exposure groups, either impact of benzene on the bone marrow since the cells were that the metabolism of benzene at 100 p.p.m. is saturated and that exposure levels Ͼ100 p.p.m. do not significantly increase Benzene exposure was associated with an increase in MN-RBC frequency in a time-dependent manner for up to 13 the levels of toxic metabolites. In this case, the mice in the 200 p.p.m. groups would be exposed to a similar total amount weeks exposure. At some point between 13 weeks and~6 months, the micronucleus frequency leveled off. The frequency of toxic metabolites but for a shorter exposure time (15 h/ week), compared with either of the 100 p.p.m. exposure of MN-RBC reported here is similar to that determined previously at 100 p.p.m. benzene exposure for up to 8-14 groups (30 h/week). This suggests that the bone marrow dose (concentrationϫtime) of benzene toxic metabolites would be weeks (Luke et al., 1988a (Luke et al., , 1988b Farris et al., 1996) .
In this study, exposure of mice to 200 p.p.m. benzene for less in the 200 p.p.m., 5 h/day, MWF exposure group than in the 100 p.p.m. exposure groups. These data indicate that 5 h/day MWF resulted in fewer MN-RBC than exposure to 100 p.p.m. in all four genotypes examined. These results are at levels of benzene where metabolism is saturated, the length of benzene exposure is more significant than the in contrast to the increased frequency at 200 p.p.m. compared with 100 p.p.m. benzene reported by Farris et al. (1996) , exposure concentration. Physiologically-based pharmacokinetic modeling of internal doismetry is in progress to assess in which there was a concentration-dependent increase in MN-RBC. However, in that study, mice were exposed to 100 levels of hydroquinone (a clastogenic metabolite of benzene) in the bone marrow for each exposure regimen (Cole et al., or 200 p.p.m. benzene for 6 h/day M-F. These findings suggest that the length of exposure, as well as the pattern of exposure 2000). These data are needed to define the role of internal dose in the micronuclei responses observed for each exposure (intermittent versus daily), are more critical to the accumulation of chromosomal damage than the actual benzene concentration.
regimen used in the present study. The observation that short-duration, high-level exposure is Benzene must first be metabolized to form the major toxic metabolites hydroquinone, catechol and trans-trans-muconic less toxic than lower, long-term exposure has been previously reported: inhalation of 3000 p.p.m. benzene for 8 days was less acid so as to be hematotoxic and/or carcinogenic (Smith, 1996) . In the present study, irrespective of the strain, mice damaging than 300 p.p.m. for 80 days (Cronkite et al., 1989) . Haploinsufficiency of p53 resulted in an equivalent or exposed to 100 p.p.m. had a greater frequency of benzeneinduced micronuclei than those exposed to 200 p.p.m. One reduced frequency of micronuclei compared with the C57BL/ 6 isotype parental controls. This finding was unexpected. Due data for the 200 p.p.m. MWF group may have resulted from collecting blood on the same day as exposure. For logistical to the role of p53 in genotoxic stress response, we originally hypothesized that the heterozygous state of p53 in the p53ϩ/-reasons the other collection time points for the MWF groups were on non-exposure days (Tuesday or Thursday). Since MNmouse strain would allow for increased survival of chromosome-damaged erythrocyte precursor cells, resulting in an RET represent recently formed micronuclei, the cytotoxicity of 200 p.p.m. benzene would reduce the formation and release increase in circulating micronucleated erythrocytes. The possibility of compensatory up-regulation of DNA damage of MN-RETs from the bone marrow immediately after exposure. response networks, DNA repair or altered regulation of apoptosis is currently under investigation in our laboratory.
There was an increased frequency of RET in the 100 p.p.m. MWF group as compared with the 100 p.p.m. M-F group Another possibility for the reduced MN-RBC frequency in the p53ϩ/-animals is small differences in benzene metabolism among all mouse genotypes examined. We hypothesize that this reflects recovery in the bone marrow between exposures rates between the genetically altered p53 model and the parental strain. However, the similar reticulocyte frequency in in the intermittent MWF exposure. Why the 200 p.p.m. MWF group did not have the same increase in RET is uncertain, but the p53ϩ/-and C57BL/6 mice in all exposure groups would suggest that the bone marrow dynamics of erythrocyte producthis may be due to reduced toxicity relative to the 100 p.p.m. MWF group. tion during benzene exposure are similar in these two strains. Although statistically significant, the differences in MN-RBC The increased frequency of RET in the Tg.AC mice as compared with the FVB/N parental strain in the 200 p.p.m. frequency may not be biologically significant. However, we can conclude that the p53ϩ/-mouse is not more sensitive to group may reflect activation of the transgene in the spleens of these animals and a resulting proliferation of erythrocytic benzene genotoxicity, as assessed by MN-RBC formation, than in the C57BL/6 wild-type. This finding is consistent with precursor cells. In mice, most erythroid expansion as a result of destruction-related anemia occurs in the spleen (Broudy previous reports that demonstrated no differences in mutation frequency or spectrum in the p53ϩ/ϩ and p53- /-genotypes et al., 1996) . Since the v-Ha-ras transgene is normally expressed in the bone marrow of the Tg.AC mice (Trempus in any of the tissues examined (Buettner et al., 1997) .
The 
